Comparative Pharmacology
Head-to-head clinical analysis: AUGMENTIN 125 versus PENTIDS 200.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AUGMENTIN 125 versus PENTIDS 200.
AUGMENTIN '125' vs PENTIDS '200'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and autolysin activation. Clavulanate is a beta-lactamase inhibitor that irreversibly binds to and inactivates beta-lactamases, preventing hydrolysis of amoxicillin.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting transpeptidation and activating autolytic enzymes.
One AUGMENTIN '125' tablet (amoxicillin 125 mg, clavulanate 31.25 mg) orally every 8 hours for mild to moderate infections.
Penicillin G benzathine: 1.2 million units intramuscularly as a single dose.
None Documented
None Documented
Amoxicillin: 1.0-1.3 hours (prolonged in renal impairment; up to 7-20 hours in anuria). Clavulanate: 0.9-1.2 hours (increased in renal impairment).
0.5-1 hour; prolonged in renal impairment; anuric patients up to 10 hours
Amoxicillin: ~50-70% excreted unchanged in urine via glomerular filtration and tubular secretion; clavulanate: ~30-50% excreted unchanged in urine. Small amounts eliminated in bile and feces.
Renal: 60-90% unchanged; biliary/fecal: 10-40%
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic